Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 49,284 shares at $6.42 ($316K) on 2020-02-25, disclosed to the SEC on 2020-02-28.
Seasonal sale ($316k) by Chief Executive Officer — this insider has traded STML in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.42 | 24,642 | $158K | 50.0% |
| 2 | $6.42 | 24,642 | $158K | 50.0% |
| Total | $6.42 avg | 49,284 | $316K | 100% |
| Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |
| STML | SELL | 2019-06-28 | $1.3M | — | Filing → |